XML 47 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Stock Warrants Outstanding to Purchase Ordinary Shares

As of December 31, 2020, the Company had the following outstanding warrants to purchase common stock:

 

Warrant   Issuance Date   Expiration Date   Exercise Price
Per Share ($)
    Number of Shares
of common stock
Underlying
Warrants
 
                     
Warrant Medigus   December 30, 2019   December 30, 2022   (*)     2,688,492  
Warrant B   December 30, 2019   June 30, 2021     0.893       6,826,623  
Warrant A   March 3, 2020   March 3, 2021     0.595       979,754  
Warrant B   March 3, 2020   September 3, 2021     0.893       1,959,504  
Warrant A   May 18, 2020   November 18, 2021     0.595       2,066,116  
Warrant B   May 18 2020   May 18, 2022     0.893       4,132,232  
Warrant A   June 23, 2020   June 23, 2021     0.595       393,736  
Warrant B   June 23,2020   December 23, 2021     0.893       787,471  
                      19,833,928  

 

(*) If ScoutCam. achieves an aggregate amount of $33 million in sales within the first three years immediately after the Exchange Agreement, the Company will issue to Medigus 2,688,492 shares of the Company’s common stock, which represents 10% of the Company’s issued and outstanding share capital as of the Exchange Agreement.

Schedule of Stock Options Activity

The following summarizes stock option activity:

 

    Amount of options     Weighted average exercise price     Weighted Average Remaining Contractual Term (years)    

 

 

Aggregate Intrinsic Value (in thousands)

 
          $           $ in thousands  
Outstanding - December 31, 2019     -       -       -          
Granted     6,633,394       0.29                  
Outstanding - December 31, 2020     6,633,394       0.29       6.23       2,446  
                                 
Options Exercisable - December 31, 2020     1,941,701       0.29       6.12       718  

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of each award is estimated using Black-Scholes option pricing model based on the following assumptions:

 

   

Year ended

December 31, 2020

 
Underlying value of ordinary shares ($)     0.446-0.800  
Exercise price ($)     0.29-0.35  
Expected volatility (%)     43.35%-45.00 %
Term of the options (years)     7  
Risk-free interest rate (%)     0.54%-1.55 %